Astellas Pharma Ltd is a member company of the Association of the British Pharmaceutical Industry (ABPI). The ABPI requires all member companies to document and disclose certain Transfers of Value they make, directly or indirectly, to or for the benefit of, Healthcare Professionals (HCPs) or Healthcare Organisations (HCOs).
Astellas Pharma Ltd discloses Transfers of Value to HCPs and HCOs in accordance with its commitment to the ABPI Code of Practice and in accordance with Data Protection regulations.
Our commitment: Astellas Pharma Ltd is fully committed to bringing greater transparency to our industry and to strengthen the public trust in the relationships between pharmaceutical companies and Healthcare Professionals. All disclosures to HCPs or HCOs can be viewed on the ABPI website.
|2020 - present||https://www.abpi.org.uk/reputation/disclosure-uk|
2019 Disclosure of Transfers of Value (TOVs) in response to COVID-19 pandemic
In response to the COVID-19 pandemic, in April 2020 the ABPI and the Prescription Medicines Code of Practice Authority (PMCPA) agreed that it would not be appropriate for industry to write to HCPs, ORDMs or HCOs to request that disclosure data be reviewed. Doing so would add additional work for NHS professionals at this time. To avoid this, and in-line with guidance provided by the ABPI, Astellas’ 2019 transfer of value data was published on Disclosure UK in aggregate.